Trial Profile

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Access Catheters.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Nov 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tenecteplase (Primary)
Indications Catheter thrombosis
Focus Therapeutic Use
Acronyms TROPICS-1
Sponsors Genentech

Most Recent Events

22 Dec 2009 New trial record
07 Dec 2009 Primary endpoint 'Catheter clearance rate' has been met.
05 Dec 2009 Results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH-2009).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com